{
  "ticker": "ATAI",
  "company_name": "ATAI",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05029401",
      "title": "A Study of Oral Ibogaine in Opioid Withdrawal",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Opiate Withdrawal Syndrome",
      "start_date": "2021-04-01",
      "completion_date": "2024-01-16",
      "enrollment": 0,
      "sponsor": "atai Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06693609",
      "title": "Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Social Anxiety Disorder",
      "start_date": "2025-04-15",
      "completion_date": "2026-02-04",
      "enrollment": 0,
      "sponsor": "atai Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06524830",
      "title": "A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Treatment Resistant Depression",
      "start_date": "2024-12-30",
      "completion_date": "2026-03-30",
      "enrollment": 0,
      "sponsor": "atai Therapeutics, Inc."
    }
  ],
  "summary": {
    "total_trials": 3,
    "by_phase": {
      "PHASE1, PHASE2": 1,
      "PHASE2": 2
    },
    "by_status": {
      "COMPLETED": 1,
      "ACTIVE_NOT_RECRUITING": 1,
      "RECRUITING": 1
    },
    "active_trials": 2,
    "completed_trials": 1,
    "conditions": [
      "Opiate Withdrawal Syndrome",
      "Social Anxiety Disorder",
      "Treatment Resistant Depression"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:45:41.226582",
    "search_query": "ATAI",
    "url": "https://clinicaltrials.gov/search?term=ATAI"
  }
}